Merrimack Pharmaceuticals
MACK
#7824
Rank
C$0.31 B
Marketcap
$21.14
Share price
0.00%
Change (1 day)
20.83%
Change (1 year)

Merrimack Pharmaceuticals (MACK) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : C$31.67 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's total liabilities are C$31.67 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Merrimack Pharmaceuticals - Total liabilities on balance sheet (from 2010 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.58 M-26.82%
2022-12-31C$0.79 M11.59%
2021-12-31C$0.71 M-27.05%
2020-12-31C$0.98 M-72.86%
2019-12-31C$3.61 M-91.06%
2018-12-31C$40.49 M53.05%
2017-12-31C$26.45 M-94.11%
2016-12-31C$0.44 B-22.67%
2015-12-31C$0.58 B92.01%
2014-12-31C$0.30 B20.6%
2013-12-31C$0.25 B62.26%
2012-12-31C$0.15 B41.99%
2011-12-31C$0.10 B-60.63%
2010-12-31C$0.27 B-3.75%
2009-12-31C$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$85.01 B 268,264.94%๐Ÿ‡ซ๐Ÿ‡ท France
C$0.10 B 219.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.21 B 573.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.06 B 3,272.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$76.86 M 142.64%๐Ÿ‡บ๐Ÿ‡ธ USA